A Pooled Analysis of Trastuzumab Deruxtecan in Patients With HER2-Positive Metastatic Breast Cancer With Brain Metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Pooled Analysis of Trastuzumab Deruxtecan in Patients With HER2-Positive Metastatic Breast Cancer With Brain Metastases

Published:2024-09 Issue: Volume: Page:
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

André F.,Cortés J.,Curigliano G.,Modi S.,Li W.,Park Y.H.,Chung W.-P.,Kim S.-B.,Yamashita T.,Pedrini J.L.,Im S.-A.,Tseng L.-M.,Harbeck N.,Krop I.,Nakatani S.,Tecson K.,Ashfaque S.,Egorov A.,Hurvitz S.A.

Funder

Daiichi Sankyo Company

AstraZeneca

Publisher

Elsevier BV

Reference46 articles.

1. Human epidermal growth factor receptor 2 (HER2) in Cancers: Overexpression and therapeutic implications;Iqbal;Mol Biol Int,2014

2. HER2: biology, detection, and clinical implications;Gutierrez;Arch Pathol Lab Med,2011

3. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;J Clin Oncol,2013

4. National Cancer Institute. SEER Cancer Stat Facts: Female breast cancer subtypes. 2024. Bethesda, MD: National Cancer Institute; 2017.

5. American Cancer Society. Breast cancer HER2 status. 2024. Atlanta, GA: American Cancer Society; 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP